mutLBSgeneDB

mutLBSgeneDB
mutated Ligand Binding Site gene DataBase

Home

Download

 Statistics

Help

About Us

Bioinformatics and Systems Medicine Laboratory Bioinformatics and Systems Medicine Laboratory

Gene Summary

Ligand Binding Site Mutation Information

Protein Structure Related Information

Gene Expression and Gene-Gene Network

Phenotype Information

Pharmacological Information

Conservation Information for LBS

Gene summary for EME1
Gene summary
Basic gene Info.Gene symbolEME1
Gene nameessential meiotic structure-specific endonuclease 1
SynonymsMMS4L|SLX2A
CytomapUCSC genome browser: 17q21.33
Type of geneprotein-coding
RefGenesNM_001166131.1,
NM_152463.2,
DescriptionMMS4 homologSLX2 structure-specific endonuclease subunit homolog Acrossover junction endonuclease EME1essential meiotic endonuclease 1 homolog 1essential meiotic endonuclease 1 homolog 2hMMS4homolog of yeast EME1 endonuclease
Modification date20141207
dbXrefs MIM : 610885
HGNC : HGNC
Ensembl : ENSG00000154920
Vega : OTTHUMG00000164974
ProteinUniProt: Q96AY2
go to UniProt's Cross Reference DB Table
ExpressionCleanEX: HS_EME1
BioGPS: 146956
PathwayNCI Pathway Interaction Database: EME1
KEGG: EME1
REACTOME: EME1
Pathway Commons: EME1
ContextiHOP: EME1
ligand binding site mutation search in PubMed: EME1
UCL Cancer Institute: EME1
Assigned class in mutLBSgeneDBC: This gene just belongs to mutLBSgenes.

Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez
GO IDGO TermPubMed ID


Top
Ligand binding site mutations for EME1
Lollipop-style diagram of mutations at LBS in amino-acid sequence.
We represented ligand binding site mutations only. (You can see big image via clicking.)
 
: non-synonymous mutation on LBS, Circle size denotes number of samples.

Cancer type specific mutLBS sorted by frequency
LBSAAchange of nsSNVCancer type# samples
D453E454DSKCM1
R544R544HTHCA1
E548E548DUCEC1
K441A442VUCEC1
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma.


Top
Protein structure related information for EME1
Relative protein structure stability change (ΔΔE) using Mupro 1.1
Mupro score denotes assessment of the effect of mutations on thermodynamic stability.
  (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability)
: nsSNV at non-LBS: nsSNV at LBS

nsSNVs sorted by the relative stability change of protein structure by each mutation
Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene.
LBSAAchange of nsSNVRelative stability change
R544R544H-1.5430473
D453E454D-1.3910607
K441A442V-0.43852515
E548E548D-0.42649871
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132)

Structure image for EME1 from PDB

Top
Differential gene expression and gene-gene network for EME1
Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types

Differential co-expressed gene network based on protein-protein interaction data (CePIN)
* Left PPI network was created from samples with mutations in the LBS of EME1 and the right PPI network was created from samples without mutations in the LBS of EME1. Only genes with p-value < 0.05 are shown.
Red circle: input gene. Orange circle: LBSgene. Blue circle: other gene.


Top

Top
Phenotype information for EME1
Gene level disease information (DisGeNet)
Disease IDDisease name# PubMedAssociation type

Mutation level pathogenic information (ClinVar annotation)
Allele IDAA changeClinical significanceOriginPhenotype IDs

Top
Pharmacological information for EME1
Drug information targeting mutLBSgene (Approved drugs only)
Drug statusDrugBank IDNameTypeDrug structure

Gene-centered ligand-gene interaction network

Ligands binding to mutated ligand binding site of EME1 go to BioLip
Ligand IDLigand short nameLigand long namePDB IDPDB namemutLBS
NUCNucleic Acids4p0sBE548
NUCNucleic Acids4p0sDE548
NUCNucleic Acids4p0sFE548
NUCNucleic Acids4p0sHE548
NUCNucleic Acids4p0rBK441
NUCNucleic Acids4p0rDK441
NUCNucleic Acids4p0sFK441
NUCNucleic Acids4p0sHK441
NUCNucleic Acids4p0qBK441 D453
NUCNucleic Acids4p0rBR544 E548


Top
Conservation information for LBS of EME1
Multiple alignments for Q96AY2 in multiple species
LBSAA sequence# speciesSpecies


Copyright © 2016-Present - The University of Texas Health Science Center at Houston
Site Policies | State of Texas